Over 7000 Dangerous
Products Have Been
Banned on Our Recommendations Worldwide



Around 3445 Hazardous Produts are in Process of Getting Banned in 37 Countries
Our Resolve is to Make Our World a Healthy Place and Save our Generations From Health Complications



We Are a Strong Force With Aim to Protect and Promote
Your Health
Associantion
Doctors
World
ANALGIN:
This is a pain-killer. Reason for ban: Bone marrow depression.
Brand name: Novalgin
CISAPRIDE:
Acidity, constipation. Reason for ban : irregular heartbeat
Brand name : Ciza, Syspride

DROPERIDOL:
Anti-depressant. Reason for ban : Irregular heartbeat.
Brand name roperol
FURAZOLIDONE:
Antidiarrhoeal. Reason for ban : Cancer.
Brand name : Furoxone, Lomofen
NIMESULIDE:
Painkiller, fever. Reason for ban : Liver failure.
Brand name : Nise, Nimulid
NITROFURAZONE:
Antibacterial cream. Reason for ban : Cancer.
Brand name : Furacin
PHENOLPHTHALEIN:
Laxative. Reason for ban : Cancer.
Brand name : Agarol
PHENYLPROPANOLAMINE:
cold and cough. Reason for ban : stroke.
Brand name : D'cold, Vicks Action-500
PIPERAZINE:
Anti-worms. Reason for ban : Nerve damage.
Brand name : Piperazine
OXYPHENBUTAZONE:
Non-steroidal anti-inflammatory drug. Reason for ban : Bone marrow depression.
Brand name : Sioril
QUINIODOCHLOR:
Anti-diarrhoeal. Reason for ban : Damage to sight.
Brand name : Enteroquinol
The decision to recommend ban or withdrawl of a drug to the regulatory authorities of different countries is normally based on the risk assessment process, which is influenced by a number of factors such as disease pattern in a country, indications and dosages of the drug permitted, varying reactions of certain ethnic groups in a given population, availability of safer substitutes and overall safety profile of the drug. These conditions are different for different countries.
It is for this reason that a drug banned / restricted in one country may continue to be marketed in other countries. There is a well laid out mechanism in India to review the status of the drug formulations as and when any serious adverse event is reported in the International journals, WDA Newsletters or when a drug formulation is reported to have been banned / withdrawn in some countries. The use of the drug, so reported, is assessed in consultation with the expert committees set up for the purpose, based on available technical information, benefit-risk ratio, local needs and availability of safer alternatives etc.
Biotechnology
Dietary Supplements
Food Defense & Emergency Response
Food Ingredients & Packaging
Guidance, Compliance & Regulatory Information
International Activities
Labeling & Nutrition
Science & Research
Emergency Preparedness
Drug Approvals and Databases
Drug Safety and Availability
Development & Approval Process (Drugs)
Guidance, Compliance & Regulatory Information
Science & Research (Drugs)
Resources for You
Products and Medical Procedures

Medical Device Safety
Device Advice: Comprehensive Regulatory Assistance
Blood & Blood Products
Cellular & Gene Therapy Products
Tissue & Tissue Products
Vaccines
Xenotransplantation
International Activities
Development & Approval Process (Biologics)
Guidance, Compliance & Regulatory Information (Biologics)
Safety & Availability (Biologics)
Immunization, Vaccines and Biologicals: haemophilus influenzae type b (Hib)
Immunization surveillance, assessment and monitoring: Haemophilus influenzae type b (Hib)
Invasive Haemophilus influenzae type B (Hib) disease prevention
Health systems
Immunization: financing
Macroeconomics and health
Pharmaceutical products
Reproductive health: health financing
Technology, Health
Alert & Response Operations
Global Outbreak Alert & Response Network
The International Food Safety Authorities Network (INFOSAN)
Chemical incidents and emergencies
International travel and health
Radiation accidents and emergencies
Health care waste
AIDS medicines and diagnostics service (AMDS)
Regulation of in vitro diagnostic devices
Technology, Health
Health workforce:education and training
World directory of medical schools
Teaching Geriatrics in Medical Education (TeGeMe) - A Study
Pharmaceutical products
Technology, Health
Immunization
Health financing
Globalization
Technical information
Immunization: Enterotoxigenic Escherichia coli
Food safety: Escherichia coli
Disease outbreaks: Enterohaemorrhagic escherischia coli infection
Chronic diseases
Environmental health
Injuries
Mental health
Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk
Prevention of recurrent heart attacks and strokes in low and middle income populations
More publications about cardiovascular diseases
Data and analysis on noncommunicable diseases

Data and analysis on blood pressure
Chronic diseases
Diet and physical exercise
Tobacco
Nutrition
Emergency Preparedness
Drug Approvals and Databases
Drug Safety and Availability
Development & Approval Process (Drugs)
Guidance, Compliance & Regulatory Information
Science & Research (Drugs)
Resources for You
Products and Medical Procedures
Medical Device Safety
Device Advice: Comprehensive Regulatory Assistance
Health workforce:education and training
World directory of medical schools
Teaching Geriatrics in Medical Education (TeGeMe) - A Study
Pharmaceutical products
Technology, Health
Immunization
Health financing
Globalization
Technical information
Immunization: Enterotoxigenic Escherichia coli
Food safety: Escherichia coli
Disease outbreaks: Enterohaemorrhagic escherischia coli infection
Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk
Prevention of recurrent heart attacks and strokes in low and middle income populations
More publications about cardiovascular diseases
The following medicines have recently been banned on the recommendation of World Doctors Association across the world:-
Recently Banned Medicines!
Popular Links
World Doctors
Association
Combination Products
Advisory Committees
Regulatory Information
Safety
Emergency Preparedness
International Programs
News & Events
Inspections/Compliance
Consumers
Industry
Click Here to Download List of Banned Medicines and Substances!
Help and Services
Contact Us
laboratory test methods
Science & Research
Employment at WDA
New Medical Ethics
Privacy
Health Professionals
Training and Continuing Education
Home l Introduction l How We Operate l Mission l Privacy l Jobs l Medical License Lookup l Members Area l Apply for Membership l Contact Us

Home
Health topics
Data and statistics
Media centre
Publications
Programmes and projects
About WDA
© World Doctors Association 2021